Media Pack
News

Current Edition

Volume 7 Issue 3

Upcoming Events

 

Advertisement

 
 
 
 
Next-generation Proximity-based Luminescence Assays & CRISPR/Cas9 Genome Engineering and nanoBRET
Volume 7 Issue 3

Next-generation Proximity-based Luminescence Assays & CRISPR/Cas9 Genome Engineering and nanoBRET

Bioluminescence resonance energy transfer (BRET) is a technology often used to probe the proximity of molecules within live cells. BRET assays have many applications...
30 September 2024 Volume 7 Issue 3 | Application Notes
Continue Reading →
Meeting Drug Development Challenges:An Insider’s View on CDMO Services for Biologics
Volume 7 Issue 3

Meeting Drug Development Challenges:An Insider’s View on CDMO Services for Biologics

As industry leaders and customers from across the globe gathered to discuss the latest trends and challenges in drug development and manufacturing at this year’s BIO...
30 September 2024 Volume 7 Issue 3 | Application Notes
Continue Reading →
Unlocking Early Drug Development Potential with CDMO Expertise
Volume 7 Issue 3

Unlocking Early Drug Development Potential with CDMO Expertise

Early-phase drug product development and manufacturing are crucial steps in transforming promising drug candidates into viable, life-changing therapies. In the fast-...
30 September 2024 Volume 7 Issue 3 | Application Notes
Continue Reading →
NK Cell Therapy – An IP Update
Volume 7 Issue 3

NK Cell Therapy – An IP Update

Advances in CAR-T cell therapy have carved a path for improved treatments in the field of oncology, in particular haematological cancers. In 2018, the European Medic...
30 September 2024 Volume 7 Issue 3 | Application Notes
Continue Reading →
Safeguarding your IP: Thermo Fisher Scientific Pharma Services’ Global Commitment to Confidentiality
Volume 7 Issue 2

Safeguarding your IP: Thermo Fisher Scientific Pharma Services’ Global Commitment to Confidentiality

Intellectual property (IP) rights and confidentiality protections play a critical role in biopharmaceutical development and manufacturing. Appropriate protections en...
3 July 2024 Volume 7 Issue 2 | Application Notes | Editorial Archives
Continue Reading →
Understanding Roller Compaction in Pharmaceutical Development
Volume 7 Issue 2

Understanding Roller Compaction in Pharmaceutical Development

David O'Connell of PCI Pharma Services explores the advancements in dry granulation and the fundamentals of roller compaction, presenting it as a viable alternative ...
3 July 2024 Volume 7 Issue 2 | Application Notes | Editorial Archives
Continue Reading →
Isosterix Uses CDD Vault to ExpediteDrug Discovery & Securely Collaborate
Volume 7 Issue 2

Isosterix Uses CDD Vault to ExpediteDrug Discovery & Securely Collaborate

SituationRoopa Rai is the Founder and CEO of Isosterix. With over 25 years of experience, Roopa has held leadership positions in discovery research in various therap...
3 July 2024 Volume 7 Issue 2 | Application Notes | Editorial Archives
Continue Reading →
A Guide to Understanding and Performing all Appropriate Validation Steps When Adopting a New Endotoxin Testing Reagent
Volume 7 Issue 1

A Guide to Understanding and Performing all Appropriate Validation Steps When Adopting a New Endotoxin Testing Reagent

Limitations of Common Endotoxin Testing Solutions The adaptation of in-house endotoxin testing for a pharmaceutical or medical device manufacturer can be a daunting ...
16 April 2024 Volume 7 Issue 1 | Application Notes
Continue Reading →
Optimising Pharmaceutical Processes: A Guide to Lyophilisation Cycle Development
Volume 7 Issue 1

Optimising Pharmaceutical Processes: A Guide to Lyophilisation Cycle Development

Lyophilisation, commonly known as freeze-drying, is a critical unit operation in the pharmaceutical industry used to preserve and stabilise both small and large-mole...
16 April 2024 Volume 7 Issue 1 | Application Notes
Continue Reading →
5,000L Single-use Bioreactors:The Next Generation in Biologics Manufacturing
Volume 7 Issue 1

5,000L Single-use Bioreactors:The Next Generation in Biologics Manufacturing

The Thermo Fisher Scientific HyPerforma™ DynaDrive™ Single-Use Bioreactor line is suited for volumes ranging from 50L to 5,000L. Optimised for modern cell culture pr...
16 April 2024 Volume 7 Issue 1 | Application Notes
Continue Reading →
 
 
 
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2024, All Rights Reserved – Powered by Teksyte